(AZE) Azelis - Ratings and Ratios

Exchange: BR • Country: Belgium • Currency: EUR • Type: Common Stock • ISIN: BE0974400328

AZE: Specialty Chemicals, Food Ingredients

Azelis Group NV is a leading global distributor of specialty chemicals and food ingredients, operating across multiple end markets. The company serves industries such as life sciences (personal care, home care, pharmaceuticals, healthcare, food and nutrition, animal nutrition, flavors and fragrances, and agricultural environmental solutions) and industrial chemicals (CASE, advanced materials and additives, lubricants, metalworking fluids, electronics, essential and fine chemicals, textiles, leather, and paper markets). With a strong presence in Europe, Middle East, and Africa (EMEA), the Americas, and the Asia-Pacific, Azelis has established itself as a key player in the specialty chemicals distribution sector. Founded in 1996 and headquartered in Antwerp, Belgium, the company employs over 3,000 professionals globally and has consistently delivered growth through strategic acquisitions and operational efficiency. Azelis has also been focusing on sustainability initiatives, aligning with global trends toward eco-friendly and responsible chemical distribution practices.

Based on current and , Azelis Group NV is expected to experience the following trends over the next three months: - Price Movement: The stock is likely to remain range-bound between 13.00 and 15.00, with the SMA 20 and SMA 50 acting as resistance levels. The recent downward trend, indicated by the gap between the last price (13.61) and the SMA 20 (15.42), suggests short-term bearish momentum. - Volatility: With an ATR of 0.67, price fluctuations are expected to remain moderate, offering limited trading opportunities for short-term investors. - Valuation: The forward P/E of 16.58 indicates improving sentiment, while the current P/E of 20.38 reflects premium pricing. The P/S ratio of 0.87 suggests the stock may be undervalued relative to its revenue generation capabilities. - Operational Performance: Azelis is likely to maintain its revenue growth trajectory, supported by its diversified market presence and strategic acquisitions. However, the RoE of 8.82% indicates room for improvement in profitability margins. - Market Sentiment: Investor sentiment may remain cautious due to elevated valuations and macroeconomic uncertainties, but the companys focus on sustainability and innovation could attract long-term investors.

Additional Sources for AZE Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

AZE Stock Overview

Market Cap in USD 4,172m
Sector Basic Materials
Industry Specialty Chemicals
GiC Sub-Industry Specialty Chemicals
IPO / Inception

AZE Stock Ratings

Growth Rating -54.3
Fundamental 60.2
Dividend Rating 50.3
Rel. Strength -38.2
Analysts -
Fair Price Momentum 11.49 EUR
Fair Price DCF 54.78 EUR

AZE Dividends

Dividend Yield 12m 1.38%
Yield on Cost 5y 0.81%
Annual Growth 5y 54.20%
Payout Consistency 93.8%

AZE Growth Ratios

Growth Correlation 3m -91.8%
Growth Correlation 12m -5.2%
Growth Correlation 5y -69.2%
CAGR 5y -17.58%
CAGR/Max DD 5y -0.34
Sharpe Ratio 12m -0.54
Alpha -46.65
Beta 0.614
Volatility 37.08%
Current Volume 251.4k
Average Volume 20d 256.5k
What is the price of AZE stocks?
As of April 30, 2025, the stock is trading at EUR 13.33 with a total of 251,354 shares traded.
Over the past week, the price has changed by -12.30%, over one month by -17.87%, over three months by -31.82% and over the past year by -41.71%.
Is Azelis a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Azelis (BR:AZE) is currently (April 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 60.16 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AZE as of April 2025 is 11.49. This means that AZE is currently overvalued and has a potential downside of -13.8%.
Is AZE a buy, sell or hold?
Azelis has no consensus analysts rating.
What are the forecast for AZE stock price target?
According to ValueRays Forecast Model, AZE Azelis will be worth about 12.7 in April 2026. The stock is currently trading at 13.33. This means that the stock has a potential downside of -5.03%.
Issuer Forecast Upside
Wallstreet Target Price 24.8 86.3%
Analysts Target Price - -
ValueRay Target Price 12.7 -5%